This announcement is a separate document:
科伦药业：关于子公司布比卡因脂质体注射液获得药品注册批准的公告
Colon Pharmaceuticals: Announcement on Subsidiary Bupivacaine Liposomal Injection Obtaining Drug Registration Approval
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated